MPWT
CYTK icon

MassMutual Private Wealth & Trust’s Cytokinetics CYTK Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2K Buy
448
+5
+1% +$359 ﹤0.01% 878
2026
Q1 		$29.2K Buy
443
+6
+1% +$381 ﹤0.01% 954
2025
Q4 		$27.8K Buy
437
+100
+30% +$6.22K ﹤0.01% 990
2025
Q3 		$18.5K Sell
337
-14
-4% -$577 ﹤0.01% 1146
2025
Q2 		$11.6K Buy
351
+159
+83% +$5.53K ﹤0.01% 1301
2025
Q1 		$7.72K Buy
192
+76
+66% +$3.49K ﹤0.01% 1397
2024
Q4 		$5.46K Hold
116
– – ﹤0.01% 1502
2024
Q3 		$6.13K Hold
116
– – ﹤0.01% 1301
2024
Q2 		$6.29K Sell
116
-5
-4% -$302 ﹤0.01% 1244
2024
Q1 		$8.48K Buy
121
+5
+4% +$387 ﹤0.01% 1089
2023
Q4 		$9.69K Sell
116
-8
-6% -$290 ﹤0.01% 1034
2023
Q3 		$3.65K Buy
124
+92
+288% +$3.06K ﹤0.01% 1344
2023
Q2 		$1.04K Sell
32
-23
-42% -$851 ﹤0.01% 1644
2023
Q1 		$1.94K Sell
55
-56
-50% -$2.29K ﹤0.01% 1430
2022
Q4 		$5K Hold
111
– – ﹤0.01% 979
2022
Q3 		$5K Buy
111
+8
+8% +$385 ﹤0.01% 936
2022
Q2 		$4K Buy
103
+79
+329% +$3.18K ﹤0.01% 949
2022
Q1 		$1K Buy
+24
New +$853 ﹤0.01% 1299

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's CYTK Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Cytokinetics (CYTK) stake by 1.1% in Q2 2026, buying an estimated $359 and bringing the position to 448 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

MassMutual Private Wealth & Trust first reported a position in CYTK in Q1 2022 and has held it in 18 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • MassMutual Private Wealth & Trust held 448 shares of Cytokinetics worth $38.2K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 5 Cytokinetics shares in Q2 2026, an estimated $359.
  • Cytokinetics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #878 holding.
  • MassMutual Private Wealth & Trust first reported a position in Cytokinetics in Q1 2022 and has held it in 18 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.